Advancing New Healthcare Solutions Through Collaboration

Honoring scientists who have significantly impacted human health—are live through February 28. If a scientist has made a significant, transformational contribution, nominate them here.

Vaccine Candidate 72% Effective in the US and 66% Effective Overall at Preventing Moderate to Severe COVID-19, 28 Days after Vaccination

Johnson & Johnson Innovation – JLABS Global Head Melinda Richter discusses how the JLABS ecosystem sought to meet the moment, emphasizing the work of JLABS companies aiming to find potential COVID-19 solutions, as well as the importance of fostering diversity and inclusion and addressing health inequities.

Johnson & Johnson Innovation is committed to helping patients, our partners and communities around the world manage the unprecedented impact of COVID-19.